bZIP transcription factors regulate conversion of nicotine to nornicotine

US11773401B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-11773401-B2
Application numberUS-201816770906-A
CountryUS
Kind codeB2
Filing dateDec 6, 2018
Priority dateDec 7, 2017
Publication dateOct 3, 2023
Grant dateOct 3, 2023

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

A method of decreasing conversion of nicotine to nornicotine is provided herein. The methods includes administering at least one basic region/leucine zipper (bZIP) type transcription factor inhibitor to an organism in need thereof. Also provided herein is a method of decreasing conversion of nicotine to nornicotine including mutating a bZIP type transcription factor binding site on a promoter of a nicotine N-demethylase (NND). Further provided herein is a method of decreasing conversion of nicotine to nornicotine including mutating a plant genome to knockout at least one bZIP type transcription factor.

First claim

Opening claim text (preview).

What is claimed is: 1. A method of decreasing conversion of nicotine to nornicotine in a Nicotiana plant, the method comprising mutating a plant genome to knockout a Nicotiana basic region/leucine zipper (bZIP) transcription factor comprising an amino acid sequence selected from the group consisting of SEQ ID NO: 2, 4, 5, and 6; and measuring expression of genes encoding nicotine demethylases, measuring nicotine levels, measuring nornicotine levels, and/or measuring N-nitrosonornicotine levels in the Nicotiana plant. 2. The method of claim 1 , wherein the Nicotiana bZIP transcription factor is a group C bZIP transcription factor. 3. The method of claim 1 , wherein the Nicotiana bZIP transcription factor is NtbZIP1a (SEQ ID NO: 2). 4. The method of claim 1 , comprising mutating the plant genome to knockout at least two of the Nicotiana bZIP transcription. 5. The method of claim 1 , wherein the Nicotiana bZIP transcription factor is a group S bZIP transcription factor. 6. The method of claim 1 , wherein the Nicotiana bZIP transcription factor is NtbZIP1b (SEQ ID NO: 4). 7. The method of claim 1 , wherein the Nicotiana bZIP transcription factor is NtbZIP2a (SEQ ID NO: 5). 8. The method of claim 1 , wherein the Nicotiana bZIP transcription factor is NtbZIP2b (SEQ ID NO: 6).

Assignees

Inventors

Classifications

  • Antisense, co-suppression, viral induced gene silencing [VIGS], post-transcriptional induced gene silencing [PTGS] · CPC title

  • Leaves · CPC title

  • Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; {Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing (when used in plants C12N15/8218)} · CPC title

  • Antisense · CPC title

  • MicroRNAs, miRNAs · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US11773401B2 cover?
A method of decreasing conversion of nicotine to nornicotine is provided herein. The methods includes administering at least one basic region/leucine zipper (bZIP) type transcription factor inhibitor to an organism in need thereof. Also provided herein is a method of decreasing conversion of nicotine to nornicotine including mutating a bZIP type transcription factor binding site on a promoter o…
Who is the assignee on this patent?
Univ Kentucky Res Found, Reynolds Tobacco Co R
What technology area does this patent fall under?
Primary CPC classification C12N15/8218. Mapped technology areas include Chemistry & Metallurgy.
When was this patent published?
Publication date Tue Oct 03 2023 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 1 related publication on this page (citations in our corpus or others sharing the same primary CPC).